Phase I–II trial of ONYX-015 in combination with MAP chemotherapy in patients with advanced sarcomas
Evanthia Galanis(Mayo Clinic in Arizona), Scott H. Okuno(Mayo Clinic), Antonio G. Nascimento(Mayo Clinic in Arizona), Bradley Lewis(Mayo Clinic in Arizona), R A Lee(Mayo Clinic in Arizona), André M. Oliveira(Mayo Clinic in Arizona), Jeffrey A. Sloan(Mayo Clinic), Pamela J. Atherton(Mayo Clinic), J H Edmonson(WinnMed), Charles Erlichman(Mayo Clinic in Arizona), Britta Randlev, Q Wang, Sally Freeman, Joseph Rubin(WinnMed)
Cited by 172
Abstract
Related Papers
No related papers found
Powered by citation graph analysis